Abstract
The prevalence of diabetes and its complications is constantly increasing worldwide, and it is responsible for increased morbidity, disability, and mortality. The most devastating consequences of diabetes are associated with its long-term micro- (retinopathy, nephropathy and neuropathy) and macrovascular complications (cardiovascular and cerebrovascular disease). Up to 75% of patients with diabetes may experience symptoms of gastrointestinal complications. The pathogenesis of gastrointestinal complications is complex, primarily related to autonomic dysfunction of the gastrointestinal tract and also associated with hyperglycemia and duration of diabetes. The metabolic and anatomic changes cause abnormalities in vascular flow, peristalsis, reflective relaxation and interstitial segmentation manifesting clinically as dysphagia, gastroparesis, diarrhea, constipation, abdominal pain, interstitial pseudo-obstruction, and anal incontinence. The management of patients with gastrointestinal complications is challenging and requires a multidisciplinary approach. Genetic components in the genesis of gastrointestinal tract disorders such as esophageal achalasia, functional dyspepsia, irritable bowel syndrome, celiac and Crohn’s disease have been established. Genetic predisposition, environmental factors such as infections and gut dysbiosis play an important role in the development of autoimmune diseases such as type 1 diabetes and Crohn’s disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Papatheodorou K, Papanas N, Banach M, Papazoglou D, Edmonds M. Complications of diabetes 2016. J Diabetes Res. 2016;2016:6989453.
Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137–88.
Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995;18:258–68.
Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–93.
Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–76.
Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27:2540–53.
Ang L, Jaiswal M, Martin C, Pop-Busui R. Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr Diab Rep. 2014;14:528.
American Diabetes Association. Microvascular complications and foot care. Sec. 10. In Standards of Medical Care in Diabetes 2018. Diabetes Care. 2018;41(Suppl. 1):S105–19.
Kahn CR, Saltiel AR. Joslin’s diabetes mellitus. 14th ed. Boston: Lippincott Williams & Wilkins; 2005. p. 145–68.
Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, Williams DE, Geiss L. Changes in diabetes-related complications in the United States 1990–2010. N Engl J Med. 2014;370:1514–23.
Krishnan B, Babu S, Walker J, Walker AB, Pappachan JM. Gastrointestinal complications of diabetes. World J Diabetes. 2013;15:51–63.
Maisey A. A practical approach to gastrointestinal complications of diabetes. Diabetes Ther. 2016;7:379–86.
Duvnjak LS. Diabetes mellitus and dyspepsia. In: Duvnjak M, editor. Dyspepsia in clinical practice. London: Springer; 2011. p. 253–65.
Rayner CK, Samson M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001;24:371–81.
Phillips LK, Rayner CK, Jones KL, Horowitz M. An update on autonomic neuropathy affecting the gastrointestinal tract. Curr Diab Rep. 2006;6:417–23.
Ohlsson B, Melander O, Thorsson O, Olsson R, Ekberg O, Sundkvist G. Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis. Diabetologia. 2006;49:2010–4.
Wilson JA, Vela MF. New esophageal function testing (impedance, Bravo pH monitoring, and high-resolution manometry): clinical relevance. Curr Gastroenterol Rep. 2008;10:222–30.
Hasler WL. Gastroparesis. Curr Opin Gastroenterol. 2012;28:621–8.
Russo A, Botten R, Kong MF, Chapman IM, Fraser RJ, Horowitz M, Sun WM. Effects of acute hyperglycemia on anorectal motor and sensory function in diabetes mellitus. Diabet Med. 2004;21:176–82.
Lysy J, Israeli E, Goldin E. The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol. 1999;94:2165–70.
Noel RA, Braun DK, Patterson RE, Bloomgren GL. Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study. Diabetes Care. 2009;32:834–8.
Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62:S47–64.
American Diabetes Association. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes 2018. Diabetes Care. 2018;41(Suppl. 1):S13–28.
Noble JA, Valdes AM, Varney MD, Carlson JA, Moonsamy P, Fear AL, Type 1 Diabetes Genetics Consortium, et al. HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes. 2010;59:2972–9.
Floyel T, Kaur S, Poicot F. Genes affecting β-cell function in type 1 diabetes. Curr Diab Rep. 2015;15:97.
Stankov K, Benc D, Draskovic D. Genetic and epigenetic factors in etiology of diabetes mellitus typus 1. Pediatrics. 2013;132:1964–74.
Knip M, Veijola R, Virtanen SM, Hyoty H, Vaarala O, Akerblom HK. Environmental triggers and determinants of type 1 diabetes. Diabetes. 2005;54(Suppl. 2):S125–36.
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–28.
Taylor R. Insulin resistance and type 2 diabetes. Diabetes. 2012;61:778–9.
Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5:150–9.
Gaulton KJ, Ferreira T, Lee Y, Raimondo A, Mägi R, Reschen ME, et al. Diabetes genetics replication and meta-analysis (DIAGRAM) consortium. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet. 2015;47:1415–25.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Diabetes Prevention Program Research Group, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2001;346:1343–50.
Phillips LS, Ratner RE, Buse JB, Kahn SE. We can change the natural history of type 2 diabetes. Diabetes Care. 2014;37:2668–76.
Laugesen E, Østergaard JA, Leslie RD. Latent autoimmune diabetes of the adult: current knowledge and uncertainty. Diabet Med. 2015;32:843–52.
Skyler JS, Bakris GL, Bonifacio E, et al. Differentiation of diabetes by pathophysiology, natural history and prognosis. Diabetes. 2017;66:241–55.
Campbell AW. Autoimmunity and the gut. Autoimmune Dis. 2014;2014:152428.
Saito YR, Mitra N, Mayer EA. Genetic approaches to functional gastrointestinal disorders. Gastroenterology. 2010;138:1276–85.
Vaarala O, Atkinson MA, Neu J. The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008;57:2555–62.
Sarnelli G, D’Alessandro A, Pesce M, Palumbo I, Cuomo R. Genetic contribution to motility disorders of the upper gastrointestinal tract. World J Gastrointest Pathophysiol. 2013;15:65–73.
Rook GA, Brunet LR. Microbes, immunoregulation, and gut. Gut. 2005;54:317–20.
Adam B, Liebregts T, Holtmann G. Mechanisms of disease: genetics of functional gastrointestinal disorders—searching the genes that matter. Nat Clin Pract Gastroenterol Hepatol. 2007;4:102–10.
Saito YA, Mitra N, Mayer EA. Genetic approaches to functional gastrointestinal disorders. Gastroenterology. 2010;138:1276–85.
Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med. 2008;359:2767–77.
Leonard MM, Cureton PA, Fasano A. Managing coeliac disease in patients with diabetes. Diabetes Obes Metab. 2015;17:3–8.
da Silva ME, Porta G, Goldberg AC, Bittencourt PL, Fukui RT, Correia MR. Diabetes mellitus-related autoantibodies in childhood autoimmune hepatitis. J Pediatr Endocrinol Metab. 2002;15:831–40.
The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature. 2007;447:661–78.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Bulum, T. (2018). Chronic Complications of Diabetes. In: Duvnjak, M., Smirčić-Duvnjak, L. (eds) Gastrointestinal Complications of Diabetes . Clinical Gastroenterology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-75856-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-75856-5_2
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-75855-8
Online ISBN: 978-3-319-75856-5
eBook Packages: MedicineMedicine (R0)